Repo Dosen ULM

TUR - 2023 - Survival of Lung Adenocarcinoma Patients with Tyrosine Kinase Inhibitor Therapy Based on EGFR Mutation Status in Tumor and Plasma Samples

Show simple item record

dc.contributor.author Oktaviyanti, Ika Kustiyah
dc.date.accessioned 2024-06-21T06:35:26Z
dc.date.available 2024-06-21T06:35:26Z
dc.date.issued 2023
dc.identifier.issn 2355-6811
dc.identifier.uri https://repo-dosen.ulm.ac.id//handle/123456789/35062
dc.publisher Indonesian Journal of Cancer en_US
dc.subject Kedokteran en_US
dc.title TUR - 2023 - Survival of Lung Adenocarcinoma Patients with Tyrosine Kinase Inhibitor Therapy Based on EGFR Mutation Status in Tumor and Plasma Samples en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account